Legal & General Group’s Eton Pharmaceutcials ETON Stock Holding History

Legal & General Group’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Buy	7,131 +4,801	+206%	+$141K	﹤0.01%	2524
2026 Q1	$57.5K	Sell	2,330 -401	-15%	-$7.01K	﹤0.01%	2656
2025 Q4	$46.2K	Sell	2,731 -121	-4%	-$2.13K	﹤0.01%	2746
2025 Q3	$62K	Hold	2,852	–	–	﹤0.01%	2693
2025 Q2	$40.6K	Buy	+2,852	New	+$45.1K	﹤0.01%	2751
2021 Q2	–	Sell	-1,838	Closed	-$13K	–	3541
2021 Q1	$13K	Hold	1,838	–	–	﹤0.01%	3305
2020 Q4	$15K	Hold	1,838	–	–	﹤0.01%	3195
2020 Q3	$15K	Sell	1,838 -551	-23%	-$3.76K	﹤0.01%	3071
2020 Q2	$13K	Buy	+2,389	New	+$11.9K	﹤0.01%	3236

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Legal & General Group's ETON Position: Q2 2026 in Review

Legal & General Group increased its Eton Pharmaceutcials (ETON) stake by 206% in Q2 2026, buying an estimated $141K and bringing the position to 7,131 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #2524.

Legal & General Group first reported a position in ETON in Q2 2020 and has held it in 9 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

Legal & General Group held 7,131 shares of Eton Pharmaceutcials worth $258K as of Q2 2026.
Legal & General Group bought 4,801 Eton Pharmaceutcials shares in Q2 2026, an estimated $141K.
Eton Pharmaceutcials made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2524 holding.
Legal & General Group first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 9 quarters since.
164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.